Dental Erosion Clinical Trial
Official title:
A Placebo Controlled Study to Evaluate the Effectiveness of Experimental Foaming Gel Toothpastes Using an In-situ Erosion Remineralization Model
Verified date | July 2014 |
Source | GlaxoSmithKline |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Food and Drug Administration |
Study type | Interventional |
The purpose of this study is to compare and evaluate the ability of two European Union (EU) regulated gel to foam toothpaste formulations versus a non-fluoride toothpaste using a modified in-situ model of dental erosion and remineralization. A positive control i.e fluoride containing toothpaste marketed in EU will also be compared to non-fluoride toothpaste.
Status | Completed |
Enrollment | 56 |
Est. completion date | February 2012 |
Est. primary completion date | February 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - General and Oral Health: Good general health with (in the opinion of the investigator) no clinically OST and OHT examinations. - Oral Requirements: - An intact maxillary dental arch suitable for the retention of the palatal appliance and an intact mandibular dental arch. Subjects may have fixed bridges replacing missing teeth. - A gum base stimulated whole saliva flow rate = 0.8 g/min and an unstimulated whole saliva flow rate = 0.2 g/min. - Contraception: Women of childbearing potential who are, in the opinion of the investigator, practicing a reliable method of contraception. Exclusion Criteria: - Oral Health: - Current active caries or periodontal disease that may compromise the study or the health of the subjects. - Lesions of the oral cavity that could interfere with the study evaluations, including severe gingivitis, grossly carious lesions, periodontitis and other severe periodontal disease. - Allergy/Intolerance: Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients. - Clinical Study/Experimental Medication: - Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit - Previous participation in this study - Substance abuse: Recent history (within the last year) of alcohol or other substance abuse. - Pregnancy: Women who are pregnant or who are intending to become pregnant over the duration of the study - Breast-feeding: Women who are breast-feeding |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Indiana University School of Dentistry | Indianapolis | Indiana |
Lead Sponsor | Collaborator |
---|---|
GlaxoSmithKline |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | RER of Enamel Specimens Post 2 Hours of Treatment Exposure | Enamel specimens were exposed to dietary erosive challenge and set of five indentations within each specimen was measured. Decrease in the indentation length compared to the baseline indicates hardening of enamel surface. Enamel specimens were exposed to second erosion challenge to determine RER which compared the indentations values of enamel specimens at baseline (B), first erosive (E1) and second erosive challenge (E2). Percent RER was calculated by formula: [(E1-E2)/ (E1-B)]*100. Smaller the negative RER, better is treatment regimen in imparting resistance to enamel. | Baseline, 2 hours post treatment in each treatment period | No |
Other | SMH Recovery of Enamel Specimens Post 2 Hours of Treatment Exposure | SMH test was used to assess mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMH was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. Percent SMH recovery was calculated from indentation values of enamel specimens at baseline (B), after in-situ hardening (R) and after first erosive challenge (E1) using formula: [(E1- R)/ (E1-B)]*100. A higher percentage values indicate a better outcome. | Baseline, 2 hours post treatment in each treatment period | No |
Primary | Relative Erosion Resistance (RER) of Enamel Specimens Post 4 Hours of Treatment Exposure | Enamel specimens were exposed to dietary erosive challenge and set of five indentations within each specimen was measured. Decrease in the indentation length compared to the baseline indicates hardening of enamel surface. Enamel specimens were exposed to second erosion challenge to determine RER which compared the indentations values of enamel specimens at baseline (B), first erosive (E1) and second erosive challenge (E2). Percent RER was calculated by formula: [(E1-E2)/ (E1-B)]*100. Smaller the negative RER, better is treatment regimen in imparting resistance to enamel. | Baseline, 4 hours post treatment in each treatment period | No |
Primary | Surface Microhardness (SMH) Recovery of Enamel Specimens Post 4 Hours of Treatment Exposure | SMH test was used to assess mineralization status of enamel specimens using a Wilson 2100 Hardness tester. SMH was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. Percent SMH recovery was calculated from indentation values of enamel specimens at baseline (B), after in-situ hardening (R) and after first erosive challenge (E1) using formula: [(E1- R)/ (E1-B)]*100. A higher percentage values indicate a better outcome. | Baseline, 4 hours post treatment in each treatment period | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04208802 -
Effect of Smoking on Saliva Composition and the Development of Dental Erosion
|
||
Not yet recruiting |
NCT04033263 -
Maintaining Oral Health With Bio-products
|
N/A | |
Completed |
NCT00752089 -
Experimental Dentifrice Remineralization/Fluoride Uptake in an in Situ Model
|
Phase 2 | |
Completed |
NCT01167543 -
Relationship and Pathophysiology of Gastroesophageal Reflux and Dental/Periodontal Disease
|
N/A | |
Completed |
NCT04095520 -
12 Months Clinical Follow-up of Non-Carious Cervical Lesions Restored With New Injectable Composite
|
N/A | |
Completed |
NCT03311438 -
Oral Health Intervention Program for Children With Congenital Heart Defects
|
N/A | |
Completed |
NCT04586322 -
Association Between Erosive Tooth Wear Progression and Dietary Risk Factors.
|
||
Enrolling by invitation |
NCT06156618 -
The Effect of Nitrate Supplement on the Oral Microbiome and Saliva in Dental Erosion
|
N/A | |
Suspended |
NCT02775149 -
Dental Erosion in Patients With Gastro-oesophageal Reflux
|
||
Active, not recruiting |
NCT05371717 -
Domiciliary Management of Dental Erosion in Patients With GERD With Biomimetic Hydroxyapatite
|
N/A | |
Completed |
NCT02780973 -
Influence of Gender Specific Differences of Saliva Composition on the Development of Dental Erosion - an In-situ Study
|
||
Completed |
NCT03426150 -
Casein Phosphopeptide--amorphous Calcium Phosphate on Human Enamel Subjected to in Vivo Acid Attacks
|
Phase 4 | |
Not yet recruiting |
NCT06171594 -
The Effect of Chlorhexidine on the Oral Microbiome and Saliva in Dental Erosion
|
N/A | |
Completed |
NCT05140538 -
A New Protocol for the Management of Dental Erosion in Rugby Players
|
N/A | |
Recruiting |
NCT02087345 -
Gastro-oesophageal Reflux in Oligosymptomatic Patients With Dental Erosion
|
||
Not yet recruiting |
NCT04602572 -
Obesity and Oral Diseases in Adult Patients
|